165 related articles for article (PubMed ID: 27825781)
1. Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits.
McNamara RK; Moser AB; Jones RI; Jandacek R; Patino LR; Strawn JR; Strakowski SM; DelBello MP
Psychiatry Res; 2016 Dec; 246():803-807. PubMed ID: 27825781
[TBL] [Abstract][Full Text] [Related]
2. Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker.
McNamara RK; Jandacek R; Tso P; Blom TJ; Welge JA; Strawn JR; Adler CM; Strakowski SM; DelBello MP
Early Interv Psychiatry; 2016 Jun; 10(3):203-11. PubMed ID: 26486098
[TBL] [Abstract][Full Text] [Related]
3. First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine.
McNamara RK; Jandacek R; Tso P; Blom TJ; Welge JA; Strawn JR; Adler CM; DelBello MP; Strakowski SM
Psychiatry Res; 2015 Dec; 230(2):447-53. PubMed ID: 26477955
[TBL] [Abstract][Full Text] [Related]
4. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder.
McNamara RK; Jandacek R; Rider T; Tso P; Dwivedi Y; Pandey GN
J Affect Disord; 2010 Oct; 126(1-2):303-11. PubMed ID: 20413162
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder.
McNamara RK; Welge JA
Bipolar Disord; 2016 May; 18(3):300-6. PubMed ID: 27087497
[TBL] [Abstract][Full Text] [Related]
6. Investigational methods for peroxisomal disorders.
Steinberg S; Jones R; Tiffany C; Moser A
Curr Protoc Hum Genet; 2008 Jul; Chapter 17():Unit 17.6. PubMed ID: 18633975
[TBL] [Abstract][Full Text] [Related]
7. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
Takemoto Y; Suzuki Y; Horibe R; Shimozawa N; Wanders RJ; Kondo N
Brain Dev; 2003 Oct; 25(7):481-7. PubMed ID: 13129591
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders.
Martínez M; Vázquez E; García-Silva MT; Manzanares J; Bertran JM; Castelló F; Mougan I
Am J Clin Nutr; 2000 Jan; 71(1 Suppl):376S-85S. PubMed ID: 10618001
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid--a new therapeutic approach to peroxisomal-disorder patients: experience with two cases.
Martinez M; Pineda M; Vidal R; Conill J; Martin B
Neurology; 1993 Jul; 43(7):1389-97. PubMed ID: 8327143
[TBL] [Abstract][Full Text] [Related]
10. Familial risk for bipolar I disorder is associated with erythrocyte omega-3 polyunsaturated fatty acid deficits in youth with attention-deficit hyperactivity disorder.
McNamara RK; Chen C; Tallman MJ; Schurdak JD; Patino LR; Blom TJ; DelBello MP
Psychiatry Res; 2022 Jul; 313():114587. PubMed ID: 35550258
[TBL] [Abstract][Full Text] [Related]
11. Zellweger syndrome knockout mouse models challenge putative peroxisomal beta-oxidation involvement in docosahexaenoic acid (22:6n-3) biosynthesis.
Infante JP; Huszagh VA
Mol Genet Metab; 2001 Jan; 72(1):1-7. PubMed ID: 11161822
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic acid mediates peroxisomal elongation, a prerequisite for peroxisome division.
Itoyama A; Honsho M; Abe Y; Moser A; Yoshida Y; Fujiki Y
J Cell Sci; 2012 Feb; 125(Pt 3):589-602. PubMed ID: 22389399
[TBL] [Abstract][Full Text] [Related]
13. Restoring the DHA levels in the brains of Zellweger patients.
Martinez M
J Mol Neurosci; 2001; 16(2-3):309-16; discussion 317-21. PubMed ID: 11478386
[TBL] [Abstract][Full Text] [Related]
14. Long-chain omega-3 polyunsaturated fatty acids in the blood of children and adolescents with juvenile bipolar disorder.
Clayton EH; Hanstock TL; Hirneth SJ; Kable CJ; Garg ML; Hazell PL
Lipids; 2008 Nov; 43(11):1031-8. PubMed ID: 18781353
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of n-3 fatty acids in bipolar patients: deficit restricted to DHA.
Pomponi M; Janiri L; La Torre G; Di Stasio E; Di Nicola M; Mazza M; Martinotti G; Bria P; Lippa S; Natili R; Pomponi MF
J Psychiatr Res; 2013 Mar; 47(3):337-42. PubMed ID: 23207113
[TBL] [Abstract][Full Text] [Related]
16. Blood polyunsaturated fatty acids in patients with peroxisomal disorders. A multicenter study.
Martinez M; Mougan I; Roig M; Ballabriga A
Lipids; 1994 Apr; 29(4):273-80. PubMed ID: 8177020
[TBL] [Abstract][Full Text] [Related]
17. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder.
McNamara RK; Jandacek R; Rider T; Tso P; Stanford KE; Hahn CG; Richtand NM
Psychiatry Res; 2008 Sep; 160(3):285-99. PubMed ID: 18715653
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendations.
McNamara RK
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):223-31. PubMed ID: 19515544
[TBL] [Abstract][Full Text] [Related]
19. Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation.
Messamore E; McNamara RK
Lipids Health Dis; 2016 Feb; 15():25. PubMed ID: 26860589
[TBL] [Abstract][Full Text] [Related]
20. Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue.
Farooqui AA; Horrocks LA
J Mol Neurosci; 2001; 16(2-3):263-72; discussion 279-84. PubMed ID: 11478381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
